Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 14;14(1):144.
doi: 10.1186/s13023-019-1111-8.

Novel genotypes and phenotypes among Chinese patients with Floating-Harbor syndrome

Affiliations

Novel genotypes and phenotypes among Chinese patients with Floating-Harbor syndrome

Shujie Zhang et al. Orphanet J Rare Dis. .

Abstract

Background: Floating-Harbor syndrome (FHS) is a rare syndromic short stature disorder caused by truncating variants in SRCAP. Few Chinese FHS patients had been reported so far and limited knowledge regarding the benefit of growth hormone treatment existed.

Methods: We ascertained 12 short stature patients with molecularly confirmed diagnosis of FHS by whole exome sequencing. We performed a comprehensive clinical evaluation for all patients and assessed the responsiveness of growth hormone treatment in a subset of the patients.

Results: Five distinct pathogenic/likely pathogenic variants were identified in 12 independent FHS patients including two previously reported variants (c.7303C > T/p.Arg2435Ter and c.7330C > T/p.Arg2444Ter) and three novel variants (c.7189G > T/p.Glu2397Ter, c.7245_7246delAT/p.Ser2416ArgfsTer26 and c.7466C > G/p.Ser2489Ter). The c.7303C > T/p.Arg2435Ter mutation appears more common in Chinese FHS patients. The clinical presentations of Chinese FHS patients are very similar to those of previously reported patients of different ethnicities. Yet we noticed micropenis and ear abnormalities in multiple patients, suggesting that these may be novel phenotypes of Floating-Harbor syndrome. Eight patients (one with GH deficiency, one with undetermined GH level, six without GH deficiency) underwent growth hormone treatment, 3 patients had good responses, one with modest and two with poor responses.

Conclusion: We described novel genotypes and phenotypes in a Chinese FHS patient cohort. We showed that about half of FHS patients exhibited modest to good response to GH treatment regardless of their respective GH deficiency status. We didn't find any correlation between different mutations and response to GH treatment.

Keywords: Chinese; Floating-Harbor syndrome; Growth hormone deficiency; SRCAP; Short stature.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Facial features of nine Chinese patients with FHS. Noticeable features included triangular face, long eyelashes, large and low-set ears, ear deformities, prominent nose, large nares, low-hanging columella, short philtrum, thin vermilion border of the upper lip and small teeth and/or widely spaced teeth
Fig. 2
Fig. 2
Hands and feet of seven Chinese patients with FHS. These photos showing brachydactyly, broad toes and thumbs, clubbing fingers, broad fingertips, the fourth and fifth fingers clinodactyly and small toenails
Fig. 3
Fig. 3
The wrist X-ray results of nine patients with FHS. These photos indicating the bone age delay in each patient. The chronological ages and corresponding bone ages are listed in Table 1
Fig. 4
Fig. 4
The Summary of reported mutations and novel mutations in FHS patients. Green dots represent mutations found in our cohort; Purple dots represent mutations previously reported in literature. Each point represent one case. The number in circle represent the times of mutations reported. The mutations marked with red color are novel mutations. Three deep blue bars represent three C-terminal AT-hook motifs. The coordinates refer to SRCAP cDNA sequence positions

References

    1. Pelletier GFM. Case report 1. Syndrome identification 1973. 1973. pp. 8–9.
    1. Leisti J, Hollister DW, Rimoin DL. The Floating-Harbor syndrome. Birth Defects Original Artic Ser. 1975;11(5):305. - PubMed
    1. Robinson PL, Shohat M, Winter RM, Conte WJ, Gordon-Nesbitt D, Feingold M, et al. A unique association of short stature, dysmorphic features, and speech impairment (Floating-Harbor syndrome) J Pediatr. 1988;113(4):703–706. doi: 10.1016/S0022-3476(88)80384-6. - DOI - PubMed
    1. White SM, Morgan A, Da Costa A, Lacombe D, Knight SJ, Houlston R, et al. The phenotype of Floating-Harbor syndrome in 10 patients. Am J Med Genet A. 2010;152A(4):821–829. doi: 10.1002/ajmg.a.33294. - DOI - PubMed
    1. Seifert W, Meinecke P, Kruger G, Rossier E, Heinritz W, Wusthof A, et al. Expanded spectrum of exon 33 and 34 mutations in SRCAP and follow-up in patients with Floating-Harbor syndrome. BMC Med Genet. 2014;15:127. doi: 10.1186/s12881-014-0127-0. - DOI - PMC - PubMed

Publication types

Substances

Supplementary concepts